SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-006448
Filing Date
2024-05-02
Accepted
2024-05-02 07:01:04
Documents
79
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20240331x10q.htm   iXBRL 10-Q 1934080
2 EX-4.1 elev-20240331xex4d1.htm EX-4.1 174701
3 EX-10.1 elev-20240331xex10d1.htm EX-10.1 162434
4 EX-31.1 elev-20240331xex31d1.htm EX-31.1 15577
5 EX-31.2 elev-20240331xex31d2.htm EX-31.2 15549
6 EX-32 elev-20240331xex32.htm EX-32 8170
  Complete submission text file 0001558370-24-006448.txt   8182239

Data Files

Seq Description Document Type Size
7 EX-101.SCH elev-20240331.xsd EX-101.SCH 50637
8 EX-101.CAL elev-20240331_cal.xml EX-101.CAL 38524
9 EX-101.DEF elev-20240331_def.xml EX-101.DEF 226133
10 EX-101.LAB elev-20240331_lab.xml EX-101.LAB 469596
11 EX-101.PRE elev-20240331_pre.xml EX-101.PRE 388808
83 EXTRACTED XBRL INSTANCE DOCUMENT elev-20240331x10q_htm.xml XML 1239808
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 24905203
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)